Show simple item record

dc.contributor.authorWoolmore, J.A.
dc.contributor.authorStone, M.J.
dc.contributor.authorHolley, S.L.
dc.contributor.authorJenkinson, P.
dc.contributor.authorIke, A.
dc.contributor.authorFryer, A.A.
dc.contributor.authorStrange, R.C.
dc.contributor.authorStephens, R.
dc.contributor.authorLangdon, D.W.
dc.contributor.authorHawkins, C.P.
dc.date.accessioned2012-11-29T11:30:01Z
dc.date.available2012-11-29T11:30:01Z
dc.date.issued2008
dc.identifier.citationWoolmore , J A , Stone , M J , Holley , S L , Jenkinson , P , Ike , A , Fryer , A A , Strange , R C , Stephens , R , Langdon , D W & Hawkins , C P 2008 , ' Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis ' , Multiple Sclerosis , vol. 14 , no. 2 , pp. 177-182 . https://doi.org/10.1177/1352458507081343
dc.identifier.issn1352-4585
dc.identifier.otherPURE: 196557
dc.identifier.otherPURE UUID: ec3bb542-b086-4823-8879-9aa1b2d701a5
dc.identifier.otherdspace: 2299/5640
dc.identifier.otherScopus: 43149119783
dc.identifier.otherORCID: /0000-0001-6887-0457/work/32418418
dc.identifier.urihttp://hdl.handle.net/2299/9251
dc.description“The final, definitive version of this article has been published in the Journal, Multiple Sclerosis, 14 (2) 2008, © SAGE Publications Ltd, 2008: on SAGE Journals Online: http://online.sagepub.com/” [Full text of this article is not available in the UHRA]
dc.description.abstractCognitive impairment occurs in 45—65% of multiple sclerosis (MS) patients. The cannabinoid system may potentially be neuroprotective in MS. We examined the relationship between polymorphisms of the CNR1 gene and neuropsychological outcome in MS using a test and confirmatory sample of patients. One hundred and ninety-four MS patients were assessed over five key areas of neuropsychological function, which are most commonly impaired in MS. The first 97 patients formed the test sample. A further confirmatory sample of 97 patients was used to test association found in the test sample. The schedule included: Wisconsin card sorting test 64 version, Rey auditory verbal learning task immediate and delayed scores, controlled oral word association task, judgement of line orientation and symbol digit modalities task. Three single nucleotide polymorphisms (SNPs) were typed within the CNR1 gene. For the overall neuropsychological assessment score we used a multiple linear regression model with selected covariates to show that subjects with the AA genotype of the SNP RS1049353 were more impaired (mean -2.47, SD 5.75, P = 0.008, Bonferroni corrected P = 0.024) than the other subjects (mean 0.24, SD 4.24). This was not confirmed when the association was retested in the confirmatory sample. No associations were identified between these CNR1 variants and cognitive impairment in MS.en
dc.language.isoeng
dc.relation.ispartofMultiple Sclerosis
dc.subjectcannabinoid receptor
dc.subjectdisease progression
dc.subjectgenetic
dc.subjectmultiple sclerosis
dc.subjectneuropsychology
dc.subjectpolymorphisms
dc.titlePolymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosisen
dc.contributor.institutionDepartment of Psychology
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionPsychology
dc.contributor.institutionCognitive Neuropsychology
dc.description.statusPeer reviewed
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1177/1352458507081343
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record